A new drug for advanced prostate cancer patients has proved so effective that researchers stopped the clinical trial early to give all patients CHICAGO (Reuters) - A trial of Johnson & Johnson's prostate cancer pill, Zytiga, found that it slowed the spread of the disease by 58 percent Small study of focal therapy by UCL shows dramatic fall in rates of incontinence and erectile problems after treatment A new prostate cancer Few available treatment options exist once prostate cancer has spread to other parts of the body and has failed to respond to therapies that UP to 4000 prostate cancer victims will get special care and support from a nurse as they battle the deadly disease under a $6 million program Initial findings from a decade ago showed that the drug finasteride significantly reduced the risk of prostate cancer, but among those who did Screening for prostate cancer could reduce deaths from the disease by about a fifth, according to the long-term results of a major European study A new prostate cancer treatment that combines lasers and deep-sea bacteria could be "truly transformative," according to a team of researchers.
In a small clinical trial, six months of treatment with the drug, Johnson & Johnson’s Zytiga, added to standard therapy, eliminated or nearly In 2012 when the United States Preventive Task Force (USPTF) recommended against PSA screening for prostate cancer many physicians and epidemiologist CALVARY Mater Newcastle researchers have helped develop a new treatment option for men with prostate cancer that does not require surgery.
J&J Drug Slows Prostate Cancer Spread by 58%: Trial Healthy men participating in the Prostate Cancer Prevention Trial who actively participate in all steps of the clinical trial are most likely Men with prostate benefit from treatment with the pioneering drug olaparib the first cancer drug to target inherited mutations according Lynparza, or olaparib, can also help men with prostate according to new clinical trial results on Tuesday.The news is the Dogs have long been considered man's best friend, but new research has revealed they may just be his best chance of diagnosing cancer too.
Clinical trials on mice said the Ailanthone (AIL) compound could help patients with an aggressive form of the cancer.
New color change test may advance cancer research
have developed a color changing test that has the potential to help advance cancer research. Patients with different types of cancer, including prostate cancer, have higher than normal levels of a protein known as AMACR and that protein is linked to
What’s new in prostate cancer? 5 things to watch
Cancer research can seem like it moves at lightning speed, with hundreds of new studies published each week. How can patients keep up with what’s new? Through its annual community symposium, the Institute for Prostate Cancer Research helps patients and
Research about side effects can help prostate cancer patients choose best treatments
For many men newly diagnosed with early-stage prostate cancer, concerns about potential quality-of-life issues often guide treatment decisions. A new study led by UNC Lineberger Comprehensive Cancer Center researchers identifies distinct patterns of side
Metastases, Not Death, New Benchmark in Prostate Cancer?
The primary endpoint of active surveillance (AS) trials should be reconsidered, a prostate cancer (PC) expert is arguing, because metastatic disease, not death from prostate cancer, is the more meaningful clinical endpoint to patients, and as such
MRI scans could save thousands of men from needless prostate cancer surgery
But major new research shows MRI checks are the most accurate way to identify prostate cancer victims. Britain currently has no national screening programme for the disease – the most common cancer in blokes. Doctors can monitor patients with a PSA test.